Tandem Diabetes Care (TNDM) FCF Margin Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,775.00 |
| Dec 31, 2025 | -1,260.00 |
| Sep 30, 2025 | -785.00 |
| Jun 30, 2025 | -2,265.00 |
| Mar 31, 2025 | 1,892.00 |
| Dec 31, 2024 | 713.00 |
| Sep 30, 2024 | -1,312.00 |
| Jun 30, 2024 | -1,037.00 |
| Mar 31, 2024 | 189.00 |
| Dec 31, 2023 | -889.00 |
| Sep 30, 2023 | 452.00 |
| Jun 30, 2023 | 991.00 |
| Mar 31, 2023 | 3,256.00 |
| Dec 31, 2022 | 4,299.00 |
| Sep 30, 2022 | 6,068.00 |
| Jun 30, 2022 | 8,410.00 |
| Mar 31, 2022 | 11,722.00 |
| Dec 31, 2021 | 5,951.00 |
| Sep 30, 2021 | 18,381.00 |
| Jun 30, 2021 | 9,145.00 |
| Mar 31, 2021 | 10,138.00 |
| Dec 31, 2020 | 5,031.00 |
| Sep 30, 2020 | 11,894.00 |
| Jun 30, 2020 | 14,471.00 |
| Mar 31, 2020 | 10,220.00 |
| Dec 31, 2019 | 8,204.00 |
| Sep 30, 2019 | 12,963.00 |
| Jun 30, 2019 | 18,423.00 |
| Mar 31, 2019 | 22,197.00 |
| Dec 31, 2018 | 15,434.00 |
| Sep 30, 2018 | 14,781.00 |
| Jun 30, 2018 | 26,432.00 |
| Mar 31, 2018 | 13,215.00 |